The latest myeloma news
Investigational drug may improve stem cell transplants for myeloma
The standard treatment for patients with multiple myeloma often includes stem cell transplantation in which…
Browsing: Myeloma
Scientists create mouse avatars to treat multiple myeloma
An international group of researchers, led by Dr José Ángel Martínez-Climent at the Cima University of…
Scientists discover new lead in hunt for myeloma drug
A molecule involved in fat transport and metabolism is key to the progression of the…
ASH 2022: Novel drug shows early promise in treating multiple myeloma
A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma,…
ASH 2022: New data for talquetamab, a first-in-class GPRC5DxCD3 bispecific antibody, suggesting durable responses in patients with heavily pretreated multiple myeloma
Results have been announced for the Phase 1/2 MonumenTAL-1 study of talquetamab, an investigational, off-the-shelf…
ASH 2022: Older or high-risk patients with newly diagnosed AML respond well to triplet therapy
Researchers observed encouraging response rates in older or high-risk patients with newly diagnosed acute myeloid…
ASH 2022: Talquetamab generates high response rate in patients with hard-to-treat multiple myeloma
In an early-phase trial, nearly three-quarters of patients who received talquetamab, a first-in-class experimental immunotherapy…
Researchers find treatment options for patients whose blood cancer relapses after CAR-T
Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers in the USA have identified…
Researchers report encouraging immunotherapy option for relapsed myeloma patients
Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the…
New immunotherapy for blood cancers
Researchers at QIMR Berghofer and Peter MacCallum Cancer Centre have discovered a new vital clue…